Clinical Trial Update: Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing an adjuvant treatment regimen for triple-negative breast cancer, involving initial EC-directed therapy followed by a tax…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Taxane (paclitaxel or docetaxel)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Breast Neoplasm | Phase 3 | Status: ACTIVE_NOT_RECRUITING